Treatment of Social Phobia

Sponsor
Boston University Charles River Campus (Other)
Overall Status
Completed
CT.gov ID
NCT00000370
Collaborator
National Institute of Mental Health (NIMH) (NIH)
1
57.1

Study Details

Study Description

Brief Summary

Social phobia is a very common and debilitating disorder, with public speaking anxiety being the most common fear. Psychologists have found that treating patients for their fear of public speaking, through cognitive-behavioral treatment (talk-based therapy) or exposure treatment (where participants participate in actual public speaking sessions), not only helps patients overcome this fear but also helps them overcome their more general social fears. However, little is known about how this change occurs during therapy. This study tries to identify the factors that contribute most to successful therapy.

Patients are assigned randomly (like tossing a coin) to 1 of 3 groups. Group 1 will receive cognitive-behavioral treatment and Group 2 will receive exposure treatment. Group 3 will not receive treatment. Study leaders will monitor patient response to treatment through behavioral tests and assessments.

An individual may be eligible for this study if he/she:

Has social phobia with public speaking anxiety.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavior therapy
  • Behavioral: Performance-based exposure therapy
  • Behavioral: Psychosocial intervention
N/A

Detailed Description

The primary goal of the present study is to identify the mediators and moderators of change in the treatment of social phobia and, in so doing suggest a common mechanism of action for all brief psychosocial interventions. Perceived self-efficacy of social behavior, negative cognitive appraisal (estimated social costs), and perceived emotional control will be considered as potential mediators; avoidant personality disorder and the generalized subtype of social phobia will be considered as potential predictors for poor treatment outcome.

Social phobia is a very prevalent and debilitating disorder, with public speaking anxiety being the most common fear among socially phobic individuals. Although there are a number of effective psychosocial treatments for social phobia (e.g., cognitive-behavioral treatments and exposure therapy) very little is known about the underlying mechanism of therapeutic change (i.e., the mediators of change), and the variables that are predictive of treatment outcome (i.e., the moderators of change). Furthermore, it is unclear why treating individuals for their public speaking anxiety can generalize to other untreated social fears.

Patients are randomly assigned to either a comprehensive cognitive-behavioral treatment for social phobia (n=43), a performance-based exposure treatment for public speaking anxiety without cognitive intervention (n=43), or a waitlist control group (n=43). Clinician ratings, behavioral tests, cognitive assessments, subjective ratings, and physiological measures are employed to determine the degree of therapeutic gains in various social phobia domains. The main hypothesis is that perceived emotional control will mediate treatment outcome and generality of effectiveness independent of the specific treatment condition.

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Treatment of Social Phobia: Mediators And Moderators
Study Start Date :
May 1, 1998
Study Completion Date :
Feb 1, 2003

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    Patients must have:

    Social phobia with public speaking anxiety.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Center for Anxiety and Related Disorders at Boston University Boston Massachusetts United States 02215

    Sponsors and Collaborators

    • Boston University Charles River Campus
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Stefan Hofmann, PhD,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stefan G. Hofmann, Professor of Psychology, Boston University Charles River Campus
    ClinicalTrials.gov Identifier:
    NCT00000370
    Other Study ID Numbers:
    • R29MH057326
    • R29MH057326
    • DSIR AT-AS
    First Posted:
    Nov 3, 1999
    Last Update Posted:
    Jan 18, 2018
    Last Verified:
    Jan 1, 2018
    Keywords provided by Stefan G. Hofmann, Professor of Psychology, Boston University Charles River Campus
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 18, 2018